|
1
|
Meng Y, Hu J, Chen Y, Yu T and Hu L:
Silencing MARCH1 suppresses proliferation, migration and invasion
of ovarian cancer SKOV3 cells via downregulation of NF-κB and
Wnt/β-catenin pathways. Oncol Rep. 36:2463–2470. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tan Y, Feng Q, Sun X, Xue M, Jiang N and
Deng X: Effects of methylseleninic acid on cisplatin-resistant
ovarian cancer cells (SKOV3/DDP) and the mechanisms. Zhong Nan Da
Xue Xue Bao Yi Xue Ban. 41:1305–1311. 2016.Chinese.
|
|
3
|
Kaur A, Sultan SH, Murugaiah V, Pathan AA,
Alhamlan FS, Karteris E and Kishore U: Human C1q induces apoptosis
in an ovarian cancer cell line via tumor necrosis factor pathway.
Front Immunol. 7:5992016. View Article : Google Scholar
|
|
4
|
Musto A, Grassetto G, Marzola MC, Rampin
L, Chondrogiannis S, Maffione AM, Colletti PM, Perkins AC, Fagioli
G and Rubello D: Management of epithelial ovarian cancer from
diagnosis to restaging: An overview of the role of imaging
techniques with particular regard to the contribution of 18F-FDG
PET/CT. Nucl Med Commun. 35:588–597. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Holschneider CH and Berek JS: Ovarian
cancer: Epidemiology, biology, and prognostic factors. Semin Surg
Oncol. 19:3–10. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
He M, Sun HG, Hao JY, Li YL, Yu JK, Yan
YY, Zhao L, Li N, Wang Y, Bai XF, et al: RNA interference-mediated
FANCF silencing sensitizes OVCAR3 ovarian cancer cells to
adriamycin through increased adriamycin-induced apoptosis dependent
on JNK activation. Oncol Rep. 29:1721–1729. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang NN, Zhao LJ, Wu LN, He MF, Qu JW,
Zhao YB, Zhao WZ, Li JS and Wang JH: Mechanistic analysis of
taxol-induced multidrug resistance in an ovarian cancer cell line.
Asian Pac J Cancer Prev. 14:4983–4988. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Concin N, Zeillinger C, Stimpfel M,
Schiebel I, Tong D, Wolff U, Reiner A, Leodolter S and Zeillinger
R: p53-dependent radio-resistance in ovarian carcinoma cell lines.
Cancer Lett. 150:191–199. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ma Y, Lu Y and Lu B: MicroRNA and long
non-coding RNA in ovarian carcinoma: Translational insights and
potential clinical applications. Cancer Invest. 34:465–476. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cocco E, Deng Y, Shapiro EM, Bortolomai I,
Lopez S, Lin K, Bellone S, Cui J, Menderes G, Black JD, et al:
Dual-targeting nanoparticles for in vivo delivery of suicide genes
to chemotherapy-resistant ovarian cancer cells. Mol Cancer Ther.
16:323–333. 2017. View Article : Google Scholar :
|
|
11
|
Shi X and Wang X: The role of MTDH/AEG-1
in the progression of cancer. Int J Clin Exp Med. 8:4795–4807.
2015.PubMed/NCBI
|
|
12
|
Wan L, Lu X, Yuan S, Wei Y, Guo F, Shen M,
Yuan M, Chakrabarti R, Hua Y, Smith HA, et al: MTDH-SND1
interaction is crucial for expansion and activity of
tumor-initiating cells in diverse oncogene- and carcinogen-induced
mammary tumors. Cancer Cell. 26:92–105. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wan L and Kang Y: Pleiotropic roles of
AEG-1/MTDH/LYRIC in breast cancer. Adv Cancer Res. 120:113–134.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Guo F, Wan L, Zheng A, Stanevich V, Wei Y,
Satyshur KA, Shen M, Lee W, Kang Y and Xing Y: Structural insights
into the tumor-promoting function of the MTDH-SND1 complex. Cell
Reports. 8:1704–1713. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tan L, Qin H, Piao Y, Liu Z, Han Y, Song F
and Xie X: Expression and clinical significance of MTDH and VEGF in
triple-negative breast cancer. Zhonghua Zhong Liu Za Zhi.
37:827–832. 2015.Chinese.
|
|
16
|
Jia X, Shan C, Xu O and Wang J: Expression
and clinical significance of MTDH, HIF-1α and TKTL1 in laryngeal
carcinoma. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi.
29:2133–2138. 2015.Chinese.
|
|
17
|
Zhao Y, Moran MS, Yang Q, Liu Q, Yuan C,
Hong S and Kong B: Metadherin regulates radioresistance in cervical
cancer cells. Oncol Rep. 27:1520–1526. 2012.PubMed/NCBI
|
|
18
|
Gu X, Wang C, Wang X, Ma G, Li Y, Cui L,
Chen Y, Zhao B and Li K: Efficient inhibition of human glioma
development by RNA interference-mediated silencing of PAK5. Int J
Biol Sci. 11:230–237. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yiwei T, Hua H, Hui G, Mao M and Xiang L:
HOTAIR interacting with MAPK1 regulates ovarian cancer skov3 cell
proliferation, migration, and invasion. Med Sci Monit.
21:1856–1863. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kanter M, Turan G, Usta C, Usta A, Esen
HH, Tavlı L, Celik C, Demirkol Y and Kanter B: Survivin and cycline
D1 expressions are associated with malignant potential in mucinous
ovarian neoplasms. J Mol Histol. 47:145–152. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Steinbichler TB, Alshaimaa A, Maria MV,
Daniel D, Herbert R, Jozsef D and Ira-Ida S: Epithelial-mesenchymal
crosstalk induces radioresistance in HNSCC cells. Oncotarget.
9:3641–3652. 2017.
|
|
22
|
No authors listed. Summaries for patients.
Screening for ovarian cancer: U.S. Preventive Services Task Force
reaffirmation recommendation statement. Ann Intern Med. 157:I–56.
2012.
|
|
23
|
Lee SG, Kang DC, DeSalle R, Sarkar D and
Fisher PB: AEG-1/MTDH/LYRIC, the beginning: Initial cloning,
structure, expression profile, and regulation of expression. Adv
Cancer Res. 120:1–38. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yuan C, Li X, Yan S, Yang Q, Liu X and
Kong B: The MTDH (−470G>A) polymorphism is associated with
ovarian cancer susceptibility. PLoS One. 7:e515612012. View Article : Google Scholar
|
|
25
|
Emdad L, Hu B, Das SK, Sarkar D and Fisher
PB: AEG-1-AKT2: A novel complex controlling the aggressiveness of
glioblastoma. Mol Cell Oncol. 2:e9950082015. View Article : Google Scholar
|
|
26
|
Emdad L, Lee SG, Su ZZ, Jeon HY, Boukerche
H, Sarkar D and Fisher PB: Astrocyte elevated gene-1 (AEG-1)
functions as an oncogene and regulates angiogenesis. Proc Natl Acad
Sci USA. 106:21300–21305. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hu G, Wei Y and Kang Y: The multifaceted
role of MTDH/AEG-1 in cancer progression. Clin Cancer Res.
15:5615–5620. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Emdad L, Sarkar D, Su ZZ, Lee SG, Kang DC,
Bruce JN, Volsky DJ and Fisher PB: Astrocyte elevated gene-1:
Recent insights into a novel gene involved in tumor progression,
metastasis and neurodegeneration. Pharmacol Ther. 114:155–170.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Haug S, Schnerch D, Halbach S, Mastroianni
J, Dumit VI, Follo M, Hasenburg A, Köhler M, Dierbach H, Herzog S,
et al: Metadherin exon 11 skipping variant enhances metastatic
spread of ovarian cancer. Int J Cancer. 136:2328–2340. 2015.
View Article : Google Scholar
|
|
30
|
He XX, Chang Y, Meng FY, Wang MY, Xie QH,
Tang F, Li PY, Song YH and Lin JS: MicroRNA-375 targets AEG-1 in
hepatocellular carcinoma and suppresses liver cancer cell growth in
vitro and in vivo. Oncogene. 31:3357–3369. 2012. View Article : Google Scholar
|
|
31
|
Zhou B, Yang J, Shu B, Liu K, Xue L, Su N,
Liu J and Xi T: Overexpression of astrocyte-elevated gene-1 is
associated with ovarian cancer development and progression. Mol Med
Rep. 11:2981–2990. 2015. View Article : Google Scholar
|
|
32
|
Li C, Chen K, Cai J, Shi QT, Li Y, Li L,
Song H, Qiu H, Qin Y and Geng JS: Astrocyte elevated gene-1: A
novel independent prognostic biomarker for metastatic ovarian
tumors. Tumour Biol. 35:3079–3085. 2014. View Article : Google Scholar
|
|
33
|
Sarkar D and Fisher PB: AEG-1/MTDH/LYRIC:
Clinical significance. Adv Cancer Res. 120:39–74. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Huang Y and Li LP: Progress of cancer
research on astrocyte elevated gene-1/Metadherin (Review). Oncol
Lett. 8:493–501. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wang Y, Zhang W, Zhu X and Wang Y, Mao X,
Xu X and Wang Y: Upregulation of AEG-1 Involves in Schwann Cell
Proliferation and Migration After Sciatic Nerve Crush. J Mol
Neurosci. 60:248–257. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yao Y, Gu X, Liu H, Wu G, Yuan D, Yang X
and Song Y: Metadherin regulates proliferation and metastasis via
actin cyto-skeletal remodelling in non-small cell lung cancer. Br J
Cancer. 111:355–364. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Park JB, Chang DG, Oh SY and Park EY:
Effect of RNA Interference-Mediated Suppression of p75 on the
Viability of Rat Notochordal Cells. Asian Spine J. 10:985–992.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhu R, Li W, Xu Y, Wan J and Zhang Z:
Upregulation of BTG1 enhances the radiation sensitivity of human
breast cancer in vitro and in vivo. Oncol Rep. 34:3017–3024. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Huerta S, Gao X, Dineen S, Kapur P, Saha D
and Meyer J: Role of p53, Bax, p21, and DNA-PKcs in radiation
sensitivity of HCT-116 cells and xenografts. Surgery. 154:143–151.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Hornhardt S, Rößler U, Sauter W,
Rosenberger A, Illig T, Bickeböller H, Wichmann HE and Gomolka M:
Genetic factors in individual radiation sensitivity. DNA Repair
(Amst). 16:54–65. 2014. View Article : Google Scholar
|
|
41
|
Emdad L, Sarkar D, Lee SG, Su ZZ, Yoo BK,
Dash R, Yacoub A, Fuller CE, Shah K, Dent P, et al: Astrocyte
elevated gene-1: A novel target for human glioma therapy. Mol
Cancer Ther. 9:79–88. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Awasthi S, Singhal SS, Awasthi YC, Martin
B, Woo JH, Cunningham CC and Frankel AE: RLIP76 and cancer. Clin
Cancer Res. 14:4372–4377. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Gnosa S, Zhang H, Brodin VP, Carstensen J,
Adell G and Sun XF: AEG-1 expression is an independent prognostic
factor in rectal cancer patients with preoperative radiotherapy: A
study in a Swedish clinical trial. Br J Cancer. 111:166–173. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Nikpour M, Emadi-Baygi M, Fischer U,
Niegisch G, Schulz WA and Nikpour P: MTDH/AEG-1 contributes to
central features of the neoplastic phenotype in bladder cancer.
Urol Oncol. 32:670–677. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Chang Y, Li B, Xu X, Shen L, Bai H, Gao F,
Zhang Z and Jonas JB: Lentivirus-mediated knockdown of astrocyte
elevated gene-1 inhibits growth and induces apoptosis through MAPK
pathways in human retinoblastoma cells. PLoS One. 11:e01487632016.
View Article : Google Scholar : PubMed/NCBI
|
